Literature DB >> 19639702

pT1 penile squamous cell carcinoma: a clinicopathologic study of 56 cases treated by CO2 laser therapy.

Maurizio Colecchia1, Nicola Nicolai, Piercesare Secchi, Gaetano Bandieramonte, Anna Maria Paganoni, Laura Maria Sangalli, Giorgio Pizzocaro, Luigi Piva, Roberto Salvioni.   

Abstract

OBJECTIVE: To evaluate the pathologic characteristics that are associated with outcomes in pT1 penile squamous cell carcinoma (SCC) treated with laser excision. STUDY
DESIGN: Peniscopic magnification and 5% acetic acid application were performed prior to CO2 laser excision. Specimens were reviewed to reassess stage, grade, invasion depth, carcinoma in situ, margins, tumor extension, lymphovascular invasion and human papillomavirus infection. Association between local recurrence (LR) and prognostic factors was established with Fisher exact test, chi2 test for categorical variables and Wilcoxon rank sum test for continuous variables.
RESULTS: After a median follow-up of 66 months, 53 of 56 patients were alive and disease free; 3 died of unrelated and intercurrent diseases. Thirteen had an LR, with 4 experiencing multiple recurrences and 1 needing a partial amputation. Two patients had inguinal nodal metastasis in 1 node. LR had a positive correlation with positive surgical margins and depth of invasion and a negative correlation with tumor extension.
CONCLUSION: Histopathologic parameters such as margin status, depth of invasion and tumor extension are predictors of LR in T1 penile SCC treated by CO2 laser excision. A logistic model could estimate each patient's risk of LR.

Entities:  

Mesh:

Year:  2009        PMID: 19639702

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  4 in total

1.  [Focal therapy for penile cancer].

Authors:  O W Hakenberg; C Protzel
Journal:  Urologe A       Date:  2016-05       Impact factor: 0.639

2.  Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life.

Authors:  Gennaro Musi; Andrea Russo; Andrea Conti; Francesco A Mistretta; Ettore Di Trapani; Stefano Luzzago; Roberto Bianchi; Giuseppe Renne; Stefano Ramoni; Matteo Ferro; Deliu Victor Matei; Marco Cusini; Luca Carmignani; Ottavio de Cobelli
Journal:  World J Urol       Date:  2017-12-02       Impact factor: 4.226

Review 3.  Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets.

Authors:  Juan Chipollini; Sharon Chaing; Mounsif Azizi; Laura C Kidd; Patricia Kim; Philippe E Spiess
Journal:  Int J Mol Sci       Date:  2017-08-16       Impact factor: 5.923

Review 4.  Penile sparing therapy for penile cancer.

Authors:  Henry Han-I Yao; Shomik Sengupta; Justin Chee
Journal:  Transl Androl Urol       Date:  2020-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.